 Treatment leptomeningeal carcinomatosis continuous intraventricular infusion recombinant man leptomeningeal carcinomatosis years treatment malignant melanoma courses recombinant continuous intraventricular infusion days first day first course lymphokine-activated killer cells rise severe elevation intracranial pressure headaches meningismus second course LAK cells course neurological status change treatment Recombinant levels U/mL courses